New York State Common Retirement Fund
ACRS icon

New York State Common Retirement Fund’s Aclaris Therapeutics ACRS Stock Holding History

New York State Common Retirement Fund’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Hold
27,300
– – ﹤0.01% 2507
2026
Q1 		$102K Hold
27,300
– – ﹤0.01% 2512
2025
Q4 		$82.2K Sell
27,300
-21,100
-44% -$53.3K ﹤0.01% 2700
2025
Q3 		$92K Sell
48,400
-15,800
-25% -$27.5K ﹤0.01% 2663
2025
Q2 		$91.2K Buy
+64,200
New +$86.9K ﹤0.01% 2744
2024
Q3 		– Sell
-586
Closed -$645 – 3178
2024
Q2 		$645 Sell
586
-7,118
-92% -$8.36K ﹤0.01% 3317
2024
Q1 		$9.55K Buy
7,704
+549
+8% +$655 ﹤0.01% 3194
2023
Q4 		$7.51K Sell
7,155
-19,888
-74% -$60.7K ﹤0.01% 3202
2023
Q3 		$185K Buy
27,043
+232
+0.9% +$1.98K ﹤0.01% 2463
2023
Q2 		$278K Sell
26,811
-47
-0.2% -$425 ﹤0.01% 2352
2023
Q1 		$217K Sell
26,858
-19,881
-43% -$252K ﹤0.01% 2549
2022
Q4 		$736K Sell
46,739
-69
-0.1% -$1.11K ﹤0.01% 2123
2022
Q3 		$737K Buy
46,808
+7,953
+20% +$125K ﹤0.01% 2133
2022
Q2 		$542K Sell
38,855
-100
-0.3% -$1.4K ﹤0.01% 2327
2022
Q1 		$672K Buy
38,955
+7,628
+24% +$104K ﹤0.01% 2280
2021
Q4 		$455K Sell
31,327
-20
-0.1% -$303 ﹤0.01% 2479
2021
Q3 		$564K Sell
31,347
-5,853
-16% -$93.8K ﹤0.01% 2397
2021
Q2 		$653K Buy
+37,200
New +$845K ﹤0.01% 2452
2020
Q2 		– Sell
-29,649
Closed -$31K – 3211
2020
Q1 		$31K Hold
29,649
– – ﹤0.01% 3061
2019
Q4 		$56K Hold
29,649
– – ﹤0.01% 3109
2019
Q3 		$32K Hold
29,649
– – ﹤0.01% 3185
2019
Q2 		$65K Hold
29,649
– – ﹤0.01% 3182
2019
Q1 		$178K Hold
29,649
– – ﹤0.01% 2769
2018
Q4 		$219K Hold
29,649
– – ﹤0.01% 2672
2018
Q3 		$431K Hold
29,649
– – ﹤0.01% 2481
2018
Q2 		$592K Buy
29,649
+5,900
+25% +$109K ﹤0.01% 2379
2018
Q1 		$416K Hold
23,749
– – ﹤0.01% 2430
2017
Q4 		$586K Buy
23,749
+2,200
+10% +$53.6K ﹤0.01% 2288
2017
Q3 		$556K Sell
21,549
-2,112
-9% -$56.6K ﹤0.01% 2309
2017
Q2 		$642K Buy
23,661
+10,877
+85% +$296K ﹤0.01% 2287
2017
Q1 		$381K Sell
12,784
-2,862
-18% -$82.5K ﹤0.01% 2505
2016
Q4 		$425K Buy
15,646
+1,434
+10% +$36.6K ﹤0.01% 2436
2016
Q3 		$364K Buy
14,212
+2,863
+25% +$60.7K ﹤0.01% 2474
2016
Q2 		$210K Buy
11,349
+8,900
+363% +$176K ﹤0.01% 2706
2016
Q1 		$46K Buy
+2,449
New +$46.8K ﹤0.01% 3073

Other funds holding ACRS

TBWA
Three Bridge Wealth Advisors Los Altos, California $399M AUM 18.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

New York State Common Retirement Fund's ACRS Position: Q2 2026 in Review

New York State Common Retirement Fund held its Aclaris Therapeutics (ACRS) position steady in Q2 2026 at 27,300 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #2507.

New York State Common Retirement Fund first reported a position in ACRS in Q1 2016 and has held it in 35 quarters since. The position peaked at $737K in Q3 2022. 25 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • New York State Common Retirement Fund held 27,300 shares of Aclaris Therapeutics worth $144K as of Q2 2026.
  • New York State Common Retirement Fund left its Aclaris Therapeutics share count unchanged in Q2 2026.
  • Aclaris Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2507 holding.
  • New York State Common Retirement Fund first reported a position in Aclaris Therapeutics in Q1 2016 and has held it in 35 quarters since.
  • New York State Common Retirement Fund's Aclaris Therapeutics position peaked at $737K in Q3 2022.
  • 25 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.